pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,297 catalysts · 3,126 8k filing · 2,032 grant · 1,000 device adverse event · 910 approval · 674 device 510k · 583 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-29×clear all
type
  • 8k filing3,126
  • grant2,032
  • device adverse event1,000
  • approval910
  • device 510k674
  • earnings583
device pma
508
  • device recall215
  • phase 2 completion172
  • recall167
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 2, 2026

    50
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoBINOSTO (ALENDRONATE SODIUM) — FDA approvalOrganon & Co.

    Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoSTIVARGA (REGORAFENIB) — FDA approvalBayer AG

    Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoDOXORUBICIN HYDROCHLORIDE — FDA approvalBAXTER INTERNATIONAL INC

    Sponsor: QILU PHARM HAINAN. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoFOSAMAX PLUS D (ALENDRONATE SODIUM) — FDA approval(alendronate sodium + cholecalciferol)

    Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL

    full page →(alendronate sodium + cholecalciferol) →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: NANG KUANG PHARM CO. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026device 510k190d agoApplied Medical Technology, Inc. — Explant Express (510k cleared)

    Product code: QVS. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoDror Orthodesign , Ltd. — ZSmile System (510k cleared)Dror Ortho-Design, Inc.

    Product code: NXC. Advisory committee: Dental. Type: Special

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoStryker GmbH — T2 Alpha Femur Retrograde Nailing System; Pangea Femur Reconstruction System (510k cleared)STRYKER CORP

    Product code: HSB. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoNingbo Runyes Medical Instrument Co., Ltd. — Diagnostic X-Ray Equipment Model POCT22 (510k cleared)

    Product code: EHD. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoCircadia Health, Inc. — The Circadia C300 System (C300) (510k cleared)

    Product code: DRT. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoMedtronic Minimed — SmartGuard Technology; Predictive Low Glucose Technology (510k cleared)

    Product code: QJI. Advisory committee: Clinical Chemistry. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoUlrich Medical USA, Inc. — Navigation Module of the Cortium® System (510k cleared)

    Product code: OLO. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoXi'An Taibo Electronic Technology Co., Ltd. — 808nm semiconductor laser hair removal machine (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoDexcom, Inc. — Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (510k cleared)DEXCOM INC

    Product code: QBJ. Advisory committee: Clinical Chemistry. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoMedacta International S.A. — MSS - Monobloc stem (510k cleared)Stemedica International S.A.

    Product code: PHX. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device pma190d agoGen-Probe Incorporated — Aptima HPV 16 18/45 Genotype Assay (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: OYB. Advisory committee: MI. Decision: APPR

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoBiotronik, Inc. — PHYLAX IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SYSTEM (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoABBOTT MEDICAL — TactiFlex Ablation Catheter SE (A-TFSE-D, A-TFSE-F, A-TFSE-J, A-TFSE-DD, A-TFSE-DF, A-TFSE-FF, A-TFSE-FJ, A-TFSE-JJ, A-T (PMA supplement)

    Supplement type: 30-Day Notice. Product code: OAE. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoGen-Probe Incorporated — APTIMA HPV ASSAY (PMA supplement)

    Supplement type: Panel Track. Product code: OYB. Advisory committee: MI. Decision: APPR

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoAbbott — CentriMag Circulatory Support System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: DSQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoBiotronik, Inc. — PHYLAX AV ICD SYSTEM (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MRM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoEdwards Lifesciences, LLC — Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve (PMA supplement)Edwards Lifesciences Corp

    Supplement type: Normal 180 Day Track No User Fee. Product code: NPT. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoBiotronik, Inc. — DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS (PMA supplement)

    Supplement type: 30-Day Notice. Product code: DXY. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoAbbott Vascular — XIENCE Alpine Everolimus Eluting Coronary Stent System (XIENCE Alpine), XIENCE Sierra Everolimus Eluting Coronary Stent (PMA supplement)Postsurgical Therapeutics Inc

    Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoBiotronik, Inc. — TUPOS LV/ATX & KRONOS LV-T CRT-D & COROX OWT STEROID LV PACING LEAD (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MRM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoBiotronik, Inc. — STRATOS LV CRT-P AND STRATOS LV-T CRT-P, COROX OTW BP LEAD AND COROX OTW-S BP LEAD (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NKE. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 3, 2026device pma190d agoMedtronic — HeartWare® HVAD System (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: DSQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 3, 2026device recall190d agoExactech, Inc. device recall (Cls II)

    Brand Name: Equinoxe Ergo Product Name: Ergo Modular Impactor Handle Model/Catalog Number: 321-09-05 — Reason: Impactor handle may be missing cross-pin — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 3, 2026device recall190d agoGE Medical Systems, LLC device recall (Cls II)

    Imactis CT-Navigation System, stereotaxic accessory for Computer Tomography (CT), systems, Model Numbers E85101LA and E85101LP — Reason: There is a potential issue that can lead to discordance between the simulated needle trajectory/tip position and the actual needle trajectory/tip position. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 3, 2026device recall190d agoExactech, Inc. device recall (Cls II)

    Brand Name: Equinoxe Product Name: Equinoxe Core Instrument Kit Model/Catalog Number: KIT-311X — Reason: Impactor handle may be missing cross-pin — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 3, 2026device recall190d agoIon Beam Applications S.A. device recall (Cls II)

    IBA Proton Therapy System - PROTEUS 235 — Reason: It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if the Healthy Signal from an external gating device is lost. This may lead to a risk of mistreatment when external gating devices are used. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 3, 2026grant190d agoUNIVERSITY OF PENNSYLVANIA — SHIV-infected rhesus macaques as a model for HIV-1 bNAb developmentUniversity of Pennsylvania

    AI grant. $803,591. PI: GEORGE M SHAW

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Deciphering Virulence Determinants of Human-Pathogenic Atypical Toxoplasma go...

    AI grant. $411,780. PI: Yifan Wang

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoUNIVERSITY OF FLORIDA — Detection of Shigella Species in Wastewater - A Pilot Study for Community and...University of Florida

    AI grant. $422,125. PI: Anthony T Maurelli

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoMETHODIST HOSPITAL RESEARCH INSTITUTE — The epigenetic regulation of alloimmune stem-like CD4+ T cells

    AI grant. $491,663. PI: Wenhao Chen

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoSLOAN-KETTERING INST CAN RESEARCH — Decoding the role of Aire-expressing Thetis cells in peripheral self-tolerance

    AI grant. $616,042. PI: Chrysothemis Brown

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoGEORGE WASHINGTON UNIVERSITY — Genetic determinants of host immunity-mediated resistance to helminth infection

    AI grant. $444,125. PI: PEDRO GAZZINELLI GUIMARAES

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoHUGO W. MOSER RES INST KENNEDY KRIEGER — GLOW: Gleaning Language trajectories and Outcomes in autistic toddlers using ...

    DC grant. $818,502. PI: Rachel Reetzke

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoUNIVERSITY OF FLORIDA — The role of B cell Cul4b in gammaherpesvirus latency and lymphomaUniversity of Florida

    AI grant. $610,971. PI: Emily K. Moser

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Resilience in Action™ : Assessing the behavioral target mechanisms of the RiA...University of California San Francisco

    MH grant. $863,276. PI: Megumi J Okumura

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Deficits in behavioral time-scale plasticity underlying imprecision and insta...University of California Los Angeles

    NS grant. $236,250. PI: Ahmet ARAC

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Contribution of type III Interferons to the pathogenesis of Staphylococcus au...

    AI grant. $762,847. PI: Dane Parker

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoVANDERBILT UNIVERSITY — Engineering Extracellular Vesicles for Tolerogenic Immunotherapy

    AI grant. $448,089. PI: John Tanner Wilson

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — Computationally predicting bacterial strain susceptibility to phages

    AI grant. $435,379. PI: Janani Ravi

    full page →nih reporter ↗
    ›Feb 3, 2026grant190d agoSTATE UNIVERSITY OF NEW YORK AT ALBANY — A-rich function for the Zika virus 3' untranslated region

    AI grant. $227,115. PI: Cara Theresia Pager

    full page →nih reporter ↗
    ← prev
    page 9 of 186
    next →
    $RDY12.45+2.47%
    $RDY12.45+2.47%
    $OGN13.65+0.22%
    $OGN13.65+0.22%
    $BAX27.61-0.61%
    $RDY12.45+2.47%
    $DROR0.00500.00%
    $SYK348.15+0.68%
    $DXCM89.53+2.14%
    $MDT90.68+1.42%
    $EW91.33-2.47%